• 11/25/2024

‘Breakthrough therapy’: a new Chinese drug shows record treatment success against one of the deadliest lung cancers

Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.

Phase 2 clinical trial of sunvozertinib shows 61 per cent anti-tumour activity response, higher than any previous candidates, according to paper in The Lancet Respiratory Medicine.

https://www.scmp.com/news/china/science/article/3245435/breakthrough-therapy-new-chinese-drug-shows-record-treatment-success-against-one-deadliest-lung?utm_source=rss_feed